IHME’s research brings together high scientific rigor with independence to play a critical role in understanding, supporting, and advancing global health. IHME’s policy reports help put our innovative research into action by translating scientific findings in order to understand specific policy implications. IHME produces an annual report on the financing of global health and also publishes special focus reports annually.
The Global Burden of Disease: Generating Evidence, Guiding Policy provides an overview of the reasons why the Global Burden of Disease (GBD) is an essential tool for evidence-based health policymaking and summarizes the main findings of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010). GBD 2010 is the most comprehensive study of its kind, producing comparative metrics for 291 different causes of premature death and disability across 187 countries, 20 age groups, and both sexes for three time periods: 1990, 2005, and 2010. The study also estimated 67 potentially preventable causes of ill health, or risk factors, such as smoking, high blood pressure, and household air pollution.
Financing Global Health 2012: The End of the Golden Age? is IHME’s fourth annual report on global health expenditure and includes preliminary estimates for health financing in the most recent years. In this year’s report, IHME built on its past data collection and analysis efforts to monitor the resources made available through development assistance for health (DAH) and government health expenditure (GHE). It confirms what many in the global health community expected: After reaching a historic high in 2010, overall DAH declined slightly in 2011, with some organizations and governments spending more and others spending less.
Financing Global Health 2011: Continued Growth as MDG Deadline Approaches offers a comprehensive view of trends in public and private financing of health assistance with preliminary estimates for health financing in the most recent years. It shows that development assistance for health (DAH) continues to rise, albeit at a slower rate than before the recession.
The IHME policy report The Challenge Ahead: Progress and Setbacks in Breast and Cervical Cancer outlines global, regional, and country trends in cancer cases, deaths, and risks over the past three decades. This is the first global assessment of country-specific trends in breast and cervical cancer for all countries by age and the findings were simultaneously published in The Lancet on September 14, 2011.
Financing Global Health 2010: Development Assistance and Country Spending in Economic Uncertainty shows the continued rise in development assistance for health globally and provides a comprehensive picture of the total amount of health funding flowing from aid agencies, governments, and private donors to developing countries.
This detailed report includes data on mortality trends for more than 180 countries over two decades. Researchers at IHME, working in collaboration with researchers at the University of Queensland, gathered vital registration data, censuses, surveys, and other sources to create datasets that were more than twice as large as those available for previous studies on maternal and child mortality.
This is the first of an annual publication providing valid and consistent time series data for tracking global health resources and offering in-depth analyses in the following three areas: development assistance for health, government health expenditure, and private health expenditure. This first report focuses on development assistance for health.